{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T13:21:38Z","timestamp":1767792098847,"version":"3.49.0"},"posted":{"date-parts":[[2026,1,5]]},"group-title":"Pathology","reference-count":31,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Satellos Bioscience","award":["Research contract"],"award-info":[{"award-number":["Research contract"]}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"crossref","award":["P50NS053672"],"award-info":[{"award-number":["P50NS053672"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,1,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Duchenne muscular dystrophy (DMD) is a devastating disease manifested in skeletal muscle by repetitious myonecrosis and regeneration. Because the regenerative process is closely linked to the cumulative severity of muscle damage, which is variably distributed within and between muscle groups, accurately quantifying muscle regeneration has remained a significant challenge.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>\n                    Myofibers are delineated by immunostaining for laminin, and subsequent image analysis employed to generate a masked outline precisely within each myofiber boundary. Morphometric parameters including minimal Feret\u2019s diameter, cross-sectional area, and circularity were measured for each myofiber. In addition, the number of Pax7-expressing satellite cells were quantified. To evaluate regenerative activity, newly formed myofibers were identified by immunostaining for expression of embryonic myosin heavy chain (eMHC). Necrotic myofibers were enumerated by immunofluorescent detection of immunoglobulin G (IgG) infiltration. The Regenerative Index (RI) was calculated as the number of regenerating (eMHC\n                    <jats:sup>+<\/jats:sup>\n                    ) myofibers divided by the number of necrotic (IgG\n                    <jats:sup>+<\/jats:sup>\n                    ) myofibers. Determination of RI was performed on muscle biopsies from 10 boys with DMD and 3 non-DMD controls of similar age.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A trend toward an increasing minimal Feret\u2019s diameter, cross-sectional area and circularity was observed with increasing age in DMD boys, with circularity showing the strongest trend. Furthermore, compared to DMD boys 7- to 8-years old, the boys 9- to 11-years old had significantly increased myofiber circularity. Pax7-expressing cells were significantly elevated in DMD boys compared to control boys of similar ages, without any observation of age-related changes. Notably, the Regenerative Index in DMD boys exhibited a pronounced decline between 7-11 years of age, and a significant inverse correlation between RI and age was observed.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Using eMHC and IgG immunostaining to calculate RI accurately assesses regeneration despite the variation in histopathologic severity between biopsies. This methodology demonstrated a significant negative correlation between RI and age of DMD boys from 7 to 11 years of age.<\/jats:p>\n                <\/jats:sec>","DOI":"10.64898\/2026.01.05.697715","type":"posted-content","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:55:27Z","timestamp":1767668127000},"source":"Crossref","is-referenced-by-count":0,"title":["Regenerative Index reveals declining muscle regeneration in paediatric patients with Duchenne muscular dystrophy"],"prefix":"10.64898","author":[{"given":"Johnathan K.","family":"Smid","sequence":"first","affiliation":[{"name":"Sprott Centre for Stem Cell Research, Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Canada"},{"name":"Satellos Bioscience, Toronto, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charis A.","family":"McPherson","sequence":"additional","affiliation":[{"name":"Sprott Centre for Stem Cell Research, Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob G.","family":"Monast","sequence":"additional","affiliation":[{"name":"Sprott Centre for Stem Cell Research, Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanti S. S.","family":"Rayagiri","sequence":"additional","affiliation":[{"name":"Sprott Centre for Stem Cell Research, Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Canada"},{"name":"Satellos Bioscience, Toronto, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven A.","family":"Moore","sequence":"additional","affiliation":[{"name":"Department of Pathology, Carver College of Medicine, University of Iowa, Iowa City, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3866-5249","authenticated-orcid":false,"given":"Michael A.","family":"Rudnicki","sequence":"additional","affiliation":[{"name":"Sprott Centre for Stem Cell Research, Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Canada"},{"name":"Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada"},{"name":"Satellos Bioscience, Toronto, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"issue":"18","key":"2026010701350468000_2026.01.05.697715v1.1","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1111\/febs.15466","article-title":"The discovery of dystrophin, the protein product of the Duchenne muscular dystrophy gene","volume":"287","year":"2020","journal-title":"FEBS J"},{"key":"2026010701350468000_2026.01.05.697715v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(87)90579-4"},{"issue":"12","key":"2026010701350468000_2026.01.05.697715v1.3","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41431-022-01138-2","article-title":"Incidence of Duchenne muscular dystrophy in the modern era; an Australian study","volume":"30","year":"2022","journal-title":"Eur J Hum Genet"},{"key":"2026010701350468000_2026.01.05.697715v1.4","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-genom-090314-025003"},{"issue":"8","key":"2026010701350468000_2026.01.05.697715v1.5","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/dmcn.15176","article-title":"Peak functional ability and age at loss of ambulation in Duchenne muscular dystrophy","volume":"64","author":"Network UKNC","year":"2022","journal-title":"Dev Med Child Neurol"},{"key":"2026010701350468000_2026.01.05.697715v1.6","doi-asserted-by":"crossref","first-page":"17562864251346326","DOI":"10.1177\/17562864251346326","article-title":"Therapeutic options for Duchenne muscular dystrophy: hope or hype?","volume":"18","year":"2025","journal-title":"Ther Adv Neurol Disord"},{"issue":"1","key":"2026010701350468000_2026.01.05.697715v1.7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s40478-023-01657-z","article-title":"Myopathologic trajectory in Duchenne muscular dystrophy (DMD) reveals lack of regeneration due to senescence in satellite cells","volume":"11","year":"2023","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"2026010701350468000_2026.01.05.697715v1.8","first-page":"94","article-title":"Markers of degeneration and regeneration in Duchenne muscular dystrophy","volume":"28","year":"2009","journal-title":"Acta Myol"},{"key":"2026010701350468000_2026.01.05.697715v1.9","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3990"},{"key":"2026010701350468000_2026.01.05.697715v1.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.08.041"},{"issue":"1","key":"2026010701350468000_2026.01.05.697715v1.11","doi-asserted-by":"crossref","first-page":"e13682","DOI":"10.1002\/jcsm.13682","article-title":"Intrinsic Muscle Stem Cell Dysfunction Contributes to Impaired Regeneration in the mdx Mouse","volume":"16","year":"2025","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"2026010701350468000_2026.01.05.697715v1.12","doi-asserted-by":"crossref","first-page":"10031","DOI":"10.1038\/s41467-025-64999-3","article-title":"Intrinsic dysfunction in muscle stem cells lacking dystrophin begins during secondary myogenesis","volume":"16","year":"2025","journal-title":"Nat Commun"},{"issue":"1","key":"2026010701350468000_2026.01.05.697715v1.13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41419-025-07755-1","article-title":"Muscle stem cells in Duchenne muscular dystrophy exhibit molecular impairments and altered cell fate trajectories impacting regenerative capacity","volume":"16","year":"2025","journal-title":"Cell Death Dis"},{"key":"2026010701350468000_2026.01.05.697715v1.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.03.044"},{"key":"2026010701350468000_2026.01.05.697715v1.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2018.10.006"},{"key":"2026010701350468000_2026.01.05.697715v1.16","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.210110"},{"key":"2026010701350468000_2026.01.05.697715v1.17","doi-asserted-by":"crossref","first-page":"16006","DOI":"10.1038\/npjregenmed.2016.6","article-title":"Targeting muscle stem cell intrinsic defects to treat Duchenne muscular dystrophy","volume":"1","year":"2016","journal-title":"NPJ Regen Med"},{"key":"2026010701350468000_2026.01.05.697715v1.18","doi-asserted-by":"crossref","unstructured":"Dubuisson N , Versele R , Planchon C , Selvais CM , Noel L , Abou-Samra M , Davis-Lopez de Carrizosa MA : Histological Methods to Assess Skeletal Muscle Degeneration and Regeneration in Duchenne Muscular Dystrophy. Int J Mol Sci 2022, 23(24).","DOI":"10.3390\/ijms232416080"},{"key":"2026010701350468000_2026.01.05.697715v1.19","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4827(86)90574-4"},{"key":"2026010701350468000_2026.01.05.697715v1.20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.Pone.0150818"},{"key":"2026010701350468000_2026.01.05.697715v1.21","doi-asserted-by":"crossref","unstructured":"Bencze M , Periou B , Baba-Amer Y , Authier FJ : Immunolabelling Myofiber Degeneration in Muscle Biopsies. J Vis Exp 2019(154).","DOI":"10.3791\/59754"},{"key":"2026010701350468000_2026.01.05.697715v1.22","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00125-9"},{"issue":"3","key":"2026010701350468000_2026.01.05.697715v1.23","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/22143602241313116","article-title":"Visualizing ambulatory performance by age and rates of decline among patients with Duchenne muscular dystrophy","volume":"12","year":"2025","journal-title":"J Neuromuscul Dis"},{"key":"2026010701350468000_2026.01.05.697715v1.24","doi-asserted-by":"crossref","unstructured":"Wang C , Yue F , Kuang S : Muscle Histology Characterization Using H&E Staining and Muscle Fiber Type Classification Using Immunofluorescence Staining. Bio Protoc 2017, 7(10).","DOI":"10.21769\/BioProtoc.2279"},{"issue":"8","key":"2026010701350468000_2026.01.05.697715v1.25","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.4103\/1673-5374.253534","article-title":"Regenerative biomarkers for Duchenne muscular dystrophy","volume":"14","year":"2019","journal-title":"Neural Regen Res"},{"key":"2026010701350468000_2026.01.05.697715v1.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2016.07.002"},{"key":"2026010701350468000_2026.01.05.697715v1.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2004.06.008"},{"key":"2026010701350468000_2026.01.05.697715v1.28","doi-asserted-by":"publisher","DOI":"10.1002\/j.2040-4603.2015.tb00646.x"},{"issue":"5","key":"2026010701350468000_2026.01.05.697715v1.29","doi-asserted-by":"crossref","first-page":"104397","DOI":"10.1016\/j.braindev.2025.104397","article-title":"Duchenne muscular dystrophy: Evolving therapeutic strategies and multidimensional evaluation approaches","volume":"47","year":"2025","journal-title":"Brain Dev"},{"key":"2026010701350468000_2026.01.05.697715v1.30","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.950651"},{"issue":"11","key":"2026010701350468000_2026.01.05.697715v1.31","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1002\/acn3.70165","article-title":"Long-Term Evaluation of Givinostat in Duchenne Muscular Dystrophy, and Natural History Comparisons","volume":"12","year":"2025","journal-title":"Ann Clin Transl Neurol"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.01.05.697715","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T09:35:18Z","timestamp":1767778518000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.01.05.697715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":31,"URL":"https:\/\/doi.org\/10.64898\/2026.01.05.697715","relation":{},"subject":[],"published":{"date-parts":[[2026,1,5]]},"subtype":"preprint"}}